Theresa Barberi, Alan D. Friedman. Engineering IL‐4 resistant proinflammatory human myeloid cells for cancer immunotherapy. // Molecular Oncology. – 2026. – DOI: 10.1002/1878-0261.70346. – URL: https://febs.onlinelibrary.wiley.com/doi/10.1002/1878-0261.70346?af=R
Theresa Barberi & Alan D. Friedman (2026). Engineering IL‐4 resistant proinflammatory human myeloid cells for cancer immunotherapy. Molecular Oncology. https://doi.org/10.1002/1878-0261.70346
Theresa Barberi and Alan D. Friedman. “Engineering IL‐4 resistant proinflammatory human myeloid cells for cancer immunotherapy.” Molecular Oncology, 2026. doi:10.1002/1878-0261.70346.
@article{Barberi2026,
title = {Engineering IL‐4 resistant proinflammatory human myeloid cells for cancer immunotherapy},
author = {Barberi, Theresa and Friedman, Alan D.},
journal = {Molecular Oncology},
year = {2026},
doi = {10.1002/1878-0261.70346},
url = {https://febs.onlinelibrary.wiley.com/doi/10.1002/1878-0261.70346?af=R}
}